[
  {
    "ts": null,
    "headline": "Zimmer Biomet (ZBH): Assessing Valuation After a Year of Weak Share Price Performance",
    "summary": "Zimmer Biomet Holdings (ZBH) has been drifting lower recently, with the stock down about 10% over the past 3 months and roughly 14% over the past year despite steady revenue and earnings growth. See our latest analysis for Zimmer Biomet Holdings. That slide reflects fading momentum rather than a collapsing business, with the latest $94.14 share price and weak recent share price returns helping explain why the 1 year total shareholder return has drifted noticeably into negative territory. If...",
    "url": "https://finnhub.io/api/news?id=9187d82ba45397099e2ffec8adffa211677522096bce7f107d710f5b3908cf3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764735937,
      "headline": "Zimmer Biomet (ZBH): Assessing Valuation After a Year of Weak Share Price Performance",
      "id": 137668374,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings (ZBH) has been drifting lower recently, with the stock down about 10% over the past 3 months and roughly 14% over the past year despite steady revenue and earnings growth. See our latest analysis for Zimmer Biomet Holdings. That slide reflects fading momentum rather than a collapsing business, with the latest $94.14 share price and weak recent share price returns helping explain why the 1 year total shareholder return has drifted noticeably into negative territory. If...",
      "url": "https://finnhub.io/api/news?id=9187d82ba45397099e2ffec8adffa211677522096bce7f107d710f5b3908cf3e"
    }
  }
]